These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 1664069)
1. Role of DBI in brain and its posttranslational processing products in normal and abnormal behavior. Guidotti A Neuropharmacology; 1991 Dec; 30(12B):1425-33. PubMed ID: 1664069 [TBL] [Abstract][Full Text] [Related]
2. Diazepam binding inhibitor (DBI): a peptide with multiple biological actions. Costa E; Guidotti A Life Sci; 1991; 49(5):325-44. PubMed ID: 1649940 [TBL] [Abstract][Full Text] [Related]
3. The role of diazepam binding inhibitor and its processing products at mitochondrial benzodiazepine receptors: regulation of steroid biosynthesis. Papadopoulos V; Berkovich A; Krueger KE Neuropharmacology; 1991 Dec; 30(12B):1417-23. PubMed ID: 1664068 [TBL] [Abstract][Full Text] [Related]
4. Diazepam binding inhibitor and its processing products stimulate mitochondrial steroid biosynthesis via an interaction with mitochondrial benzodiazepine receptors. Papadopoulos V; Berkovich A; Krueger KE; Costa E; Guidotti A Endocrinology; 1991 Sep; 129(3):1481-8. PubMed ID: 1651852 [TBL] [Abstract][Full Text] [Related]
5. Diazepam binding inhibitor (DBI) increases after acute stress in rat. Ferrarese C; Mennini T; Pecora N; Pierpaoli C; Frigo M; Marzorati C; Gobbi M; Bizzi A; Codegoni A; Garattini S Neuropharmacology; 1991 Dec; 30(12B):1445-52. PubMed ID: 1664070 [TBL] [Abstract][Full Text] [Related]
6. Diazepam binding inhibitor (DBI) processing: immunohistochemical studies in the rat brain. Alho H; Bovolin P; Slobodyansky E Neurochem Res; 1990 Feb; 15(2):209-16. PubMed ID: 2159126 [TBL] [Abstract][Full Text] [Related]
7. Diazepam-binding inhibitor (DBI)-processing products, acting at the mitochondrial DBI receptor, mediate adrenocorticotropic hormone-induced steroidogenesis in rat adrenal gland. Cavallaro S; Korneyev A; Guidotti A; Costa E Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10598-602. PubMed ID: 1279686 [TBL] [Abstract][Full Text] [Related]
9. Immunohistochemistry of diazepam binding inhibitor (DBI) in the central nervous system and peripheral organs: its possible role as an endogenous regulator of different types of benzodiazepine receptors. Alho H; Harjuntausta T; Schultz R; Pelto-Huikko M; Bovolin P Neuropharmacology; 1991 Dec; 30(12B):1381-6. PubMed ID: 1664066 [TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal fluid content of diazepam binding inhibitor in chronic hepatic encephalopathy. Rothstein JD; McKhann G; Guarneri P; Barbaccia ML; Guidotti A; Costa E Ann Neurol; 1989 Jul; 26(1):57-62. PubMed ID: 2549847 [TBL] [Abstract][Full Text] [Related]
11. A natural processing product of rat diazepam binding inhibitor, triakontatetraneuropeptide (diazepam binding inhibitor 17-50) contains an alpha-helix, which allows discrimination between benzodiazepine binding site subtypes. Berkovich A; McPhie P; Campagnone M; Guidotti A; Hensley P Mol Pharmacol; 1990 Feb; 37(2):164-72. PubMed ID: 2154668 [TBL] [Abstract][Full Text] [Related]
12. CSF diazepam-binding inhibitor in alcoholics and normal controls. Roy A; DeJong J; Adinoff B; Barbaccia M; Costa E; Guidotti A; Linnoila M Psychiatry Res; 1990 Mar; 31(3):261-6. PubMed ID: 2333358 [TBL] [Abstract][Full Text] [Related]
13. Co-localization and co-release of GABA and putative allosteric modulators of GABA receptor. Ferrarese C; Alho H; Guidotti A; Costa E Neuropharmacology; 1987 Jul; 26(7B):1011-8. PubMed ID: 2821427 [TBL] [Abstract][Full Text] [Related]
14. CSF diazepam binding inhibitor and schizophrenia: clinical and biochemical relationships. van Kammen DP; Guidotti A; Kelley ME; Gurklis J; Guarneri P; Gilbertson MW; Yao JK; Peters J; Costa E Biol Psychiatry; 1993 Oct; 34(8):515-22. PubMed ID: 8274578 [TBL] [Abstract][Full Text] [Related]
15. Isolation and characterization of a rat brain triakontatetraneuropeptide, a posttranslational product of diazepam binding inhibitor: specific action at the Ro 5-4864 recognition site. Slobodyansky E; Guidotti A; Wambebe C; Berkovich A; Costa E J Neurochem; 1989 Oct; 53(4):1276-84. PubMed ID: 2769267 [TBL] [Abstract][Full Text] [Related]
16. Modulation of insulin secretion by diazepam binding inhibitor and its processing products. Borboni P; Condorelli L; De Stefanis P; Sesti G; Lauro R Neuropharmacology; 1991 Dec; 30(12B):1399-403. PubMed ID: 1664067 [TBL] [Abstract][Full Text] [Related]
17. Distribution and characterization of diazepam binding inhibitor (DBI) in peripheral tissues of rat. Bovolin P; Schlichting J; Miyata M; Ferrarese C; Guidotti A; Alho H Regul Pept; 1990 Jul; 29(2-3):267-81. PubMed ID: 2171047 [TBL] [Abstract][Full Text] [Related]
18. Diazepam-binding inhibitor and corticotropin-releasing hormone in cerebrospinal fluid. Roy A; Pickar D; Gold P; Barbaccia M; Guidotti A; Costa E; Linnoila M Acta Psychiatr Scand; 1989 Sep; 80(3):287-91. PubMed ID: 2816471 [TBL] [Abstract][Full Text] [Related]
19. "Prolegomena" to the biology of the diazepam binding inhibitor (DBI). Costa E Neuropharmacology; 1991 Dec; 30(12B):1357-64. PubMed ID: 1664065 [TBL] [Abstract][Full Text] [Related]
20. DBI (diazepam binding inhibitor): the precursor of a family of endogenous modulators of GABAA receptor function. History, perspectives, and clinical implications. Barbaccia ML; Berkovich A; Guarneri P; Slobodyansky E Neurochem Res; 1990 Feb; 15(2):161-8. PubMed ID: 2159121 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]